Position in BIIB
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$145,192
+$36,478 QoQ
Shares Held
672
+13.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#779
of 1,036 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wilkerson Advisory Group LLC holds $3,982,457 across 10 Drug Manufacturers - General names. BIIB ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,463 | $1,754,766 | |
| 2 | JNJ |
Johnson & Johnson
|
2,677 | $679,877 | |
| 3 | ABBV |
AbbVie Inc.
|
1,624 | $408,663 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,053 | $392,310 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,102 | $293,977 | |
| 6 | AZN |
Astrazeneca PLC
|
974 | $184,689 | |
| 7 | BIIB |
Biogen Inc.
This page
|
672 | $145,192 | |
| 8 | PFE |
Pfizer Inc
|
2,885 | $69,470 |
All Filings in BIIB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,192 | 672 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $108,714 | 593 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $45,581 | 259 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||